Linkage of a triple helix-forming oligonucleotide to amsacrine-4-carboxamide derivatives modulates the sequence-selectivity of topoisomerase II-mediated DNA cleavage

被引:7
作者
Arimondo, P
Bailly, C
Boutorine, A
Asseline, U
Sun, JS
Garestier, T
Hélène, C
机构
[1] Museum Natl Hist Nat, UMR 8646 CNRS, INSERM U201, Biophys Lab, F-75005 Paris, France
[2] IRCL, Ctr Oscar Lambret, INSERM U 524, F-59045 Lille, France
[3] IRCL, Ctr Oscar Lambret, Lab Pharmacol Antitumorale, F-59045 Lille, France
[4] Ctr Biophys Mol, CNRS UPR 4301, F-45071 Orleans 2, France
关键词
D O I
10.1080/15257770008033044
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
sAmsacrine-4-carboxamide-oligonucleotide conjugates were synthesized and studied for their capacity to form DNA triple helices and to after human topoisomerase II binding and cleavage properties. The intercalating agent was attached to the 3'- or the 5'-end of a 24 nt triple helix-forming oligonucleotide via linkers of different lengths. The stability of these DNA triple helices was investigated by gel retardation and melting temperature studies using a synthetic 70 bp DNA duplex target. The effect of the conjugates on DNA cleavage by topoisomerase II was evaluated using the 70 bp duplex and a 311 bp restriction fragment containing the same triple helix site. The conjugate with the amsacrine derivative linked to the 3' end of the TFO via a hexaethylene glycol linker modulates the extent of DNA cleavage by topoisomerase II at specific sites.
引用
收藏
页码:1205 / 1218
页数:14
相关论文
共 21 条
[1]   Triple helix formation by (G,A)-containing oligonucleotides:: Asymmetric sequence effect [J].
Arimondo, PB ;
Barcelo, F ;
Sun, JS ;
Maurizot, JC ;
Garestier, T ;
Hélène, C .
BIOCHEMISTRY, 1998, 37 (47) :16627-16635
[2]  
ARIMONDO PB, 1999, IN PRESS COMPTES REN
[3]   NUCLEIC-ACID BINDING-MOLECULES WITH HIGH-AFFINITY AND BASE SEQUENCE SPECIFICITY - INTERCALATING AGENTS COVALENTLY LINKED TO OLIGODEOXYNUCLEOTIDES [J].
ASSELINE, U ;
DELARUE, M ;
LANCELOT, G ;
TOULME, F ;
THUONG, NT ;
MONTENAYGARESTIER, T ;
HELENE, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (11) :3297-3301
[4]  
Asseline U, 1997, NEW J CHEM, V21, P5
[5]   CONFORMATIONAL DRUG DETERMINANTS OF THE SEQUENCE SPECIFICITY OF DRUG-STIMULATED TOPOISOMERASE-II DNA CLEAVAGE [J].
CAPRANICO, G ;
PALUMBO, M ;
TINELLI, S ;
MABILIA, M ;
POZZAN, A ;
ZUNINO, F .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 235 (04) :1218-1230
[6]   AMSACRINE - A REVIEW [J].
CASSILETH, PA ;
GALE, RP .
LEUKEMIA RESEARCH, 1986, 10 (11) :1257-1265
[7]   Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: Cryptolepine, matadine, and serpentine [J].
Dassonneville, L ;
Bonjean, K ;
De Pauw-Gillet, MC ;
Colson, P ;
Houssier, C ;
Quetin-Leclercq, J ;
Angenot, L ;
Bailly, C .
BIOCHEMISTRY, 1999, 38 (24) :7719-7726
[8]   From amsacrine to DACA (N-[2-(dimethylamino)ethyl]acridine-4-carboxamide): Selectivity for topoisomerases I and II among acridine derivatives [J].
Finlay, GJ ;
Riou, JF ;
Baguley, BC .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (04) :708-714
[9]  
GODOVIKOVA TS, 1986, BIOORG KHIM+, V12, P475
[10]  
Henichart JP, 1997, MOL PHARMACOL, V51, P448